159 related articles for article (PubMed ID: 22026122)
21. Development of orally disintegrating tablets of Perphenazine/hydroxypropyl-β-cyclodextrin inclusion complex.
Wang L; Zeng F; Zong L
Pharm Dev Technol; 2013; 18(5):1101-10. PubMed ID: 22759202
[TBL] [Abstract][Full Text] [Related]
22. Comparison of cefpodoxime proxetil release and antimicrobial activity from tablet formulations: complexation with hydroxypropyl-β-cyclodextrin in the presence of water soluble polymer.
Gundogdu E; Koksal C; Karasulu E
Drug Dev Ind Pharm; 2012 Jun; 38(6):689-96. PubMed ID: 22010782
[TBL] [Abstract][Full Text] [Related]
23. Improvement of water solubility and in vitro dissolution rate of aceclofenac by complexation with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
Ranpise NS; Kulkarni NS; Mair PD; Ranade AN
Pharm Dev Technol; 2010; 15(1):64-70. PubMed ID: 19505225
[TBL] [Abstract][Full Text] [Related]
24. Effect of diethyl-beta-cyclodextrin on the release of nitroglycerin from formulations.
Umemura M; Ueda H; Tomono K; Nagai T
Drug Des Deliv; 1990 Oct; 6(4):297-310. PubMed ID: 2128021
[TBL] [Abstract][Full Text] [Related]
25. Cyclodextrin inclusion complex of racecadotril: effect of drug-β- cyclodextrin ratio and the method of complexation.
Semalty M; Panchpuri M; Singh D; Semalty A
Curr Drug Discov Technol; 2014 Jun; 11(2):154-61. PubMed ID: 24188445
[TBL] [Abstract][Full Text] [Related]
26. Effect of cyclodextrin complexation on aqueous solubility and photostability of phenothiazine.
Lutka A
Pharmazie; 2000 Feb; 55(2):120-3. PubMed ID: 10723770
[TBL] [Abstract][Full Text] [Related]
27. Fosinopril-cyclodextrin inclusion complexes: phase solubility and physicochemical analysis.
Sbârcea L; Udrescu L; Drăgan L; Trandafirescu C; Szabadai Z; Bojiţă M
Pharmazie; 2011 Aug; 66(8):584-9. PubMed ID: 21901980
[TBL] [Abstract][Full Text] [Related]
28. An optimized commercially feasible milling technique for molecular encapsulation of meloxicam in β-cyclodextrin.
Bandarkar FS; Vavia PR
Drug Dev Ind Pharm; 2011 Nov; 37(11):1318-28. PubMed ID: 21506882
[TBL] [Abstract][Full Text] [Related]
29. Inclusion complex of trimethoprim with beta-cyclodextrin.
Li N; Zhang YH; Wu YN; Xiong XL; Zhang YH
J Pharm Biomed Anal; 2005 Sep; 39(3-4):824-9. PubMed ID: 16011886
[TBL] [Abstract][Full Text] [Related]
30. Direct compression tablets containing a series of four beta-cyclodextrin complexes formed by neutralizing an acidic drug.
Moore E; Bergamo R; Casella R
Drug Dev Ind Pharm; 2000 Dec; 26(12):1259-70. PubMed ID: 11147126
[TBL] [Abstract][Full Text] [Related]
31. Characterization of the 13-cis-retinoic acid/cyclodextrin inclusion complexes by phase solubility, photostability, physicochemical and computational analysis.
Yap KL; Liu X; Thenmozhiyal JC; Ho PC
Eur J Pharm Sci; 2005 May; 25(1):49-56. PubMed ID: 15854800
[TBL] [Abstract][Full Text] [Related]
32. (13)C and (15)N solid-state NMR studies on albendazole and cyclodextrin albendazole complexes.
Ferreira MJ; García A; Leonardi D; Salomon CJ; Lamas MC; Nunes TG
Carbohydr Polym; 2015 Jun; 123():130-5. PubMed ID: 25843843
[TBL] [Abstract][Full Text] [Related]
33. Dissolution properties and characterization of halofantrine-2-hydroxypropyl-beta-cyclodextrin binary systems.
Onyeji CO; Omoruyi SI; Oladimeji FA
Pharmazie; 2007 Nov; 62(11):858-63. PubMed ID: 18065103
[TBL] [Abstract][Full Text] [Related]
34. Influence of soluble and insoluble cyclodextrin polymers on drug release from hydroxypropyl methylcellulose tablets.
Zugasti ME; Zornoza A; Goñi Mdel M; Isasi JR; Vélaz I; Martín C; Sánchez M; Martínez-Ohárriz MC
Drug Dev Ind Pharm; 2009 Oct; 35(10):1264-70. PubMed ID: 19555243
[TBL] [Abstract][Full Text] [Related]
35. In vitro and in vivo evaluation of novel immediate release carbamazepine tablets: complexation with hydroxypropyl-β-cyclodextrin in the presence of HPMC.
Kou W; Cai C; Xu S; Wang H; Liu J; Yang D; Zhang T
Int J Pharm; 2011 May; 409(1-2):75-80. PubMed ID: 21371541
[TBL] [Abstract][Full Text] [Related]
36. Theoretical and experimental study of a praziquantel and beta-cyclodextrin inclusion complex using molecular mechanic calculations and H1-nuclear magnetic resonance.
de Jesus MB; de Matos Alves Pinto L; Fraceto LF; Takahata Y; Lino AC; Jaime C; de Paula E
J Pharm Biomed Anal; 2006 Jun; 41(4):1428-32. PubMed ID: 16678375
[TBL] [Abstract][Full Text] [Related]
37. Development of effervescent tablets containing benzonidazole complexed with cyclodextrin.
Maximiano FP; Costa GH; de Sá Barreto LC; Bahia MT; Cunha-Filho MS
J Pharm Pharmacol; 2011 Jun; 63(6):786-93. PubMed ID: 21585376
[TBL] [Abstract][Full Text] [Related]
38. Inclusion complex and nanoclusters of cyclodextrin to increase the solubility and efficacy of albendazole.
Pacheco PA; Rodrigues LNC; Ferreira JFS; Gomes ACP; Veríssimo CJ; Louvandini H; Costa RLD; Katiki LM
Parasitol Res; 2018 Mar; 117(3):705-712. PubMed ID: 29327323
[TBL] [Abstract][Full Text] [Related]
39. Albendazole-cyclodextrin complex: enhanced cytotoxicity in ovarian cancer cells.
Pourgholami MH; Wangoo KT; Morris DL
Anticancer Res; 2008; 28(5A):2775-9. PubMed ID: 19035309
[TBL] [Abstract][Full Text] [Related]
40. In vitro and in vivo evaluation of oral tablet formulations prepared with ketoconazole and hydroxypropyl-beta-cyclodextrin.
Taneri F; Ozcan I; Guneri T
Drug Deliv; 2010 Apr; 17(3):152-7. PubMed ID: 20148713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
